logo

For the Inventor, By the Inventor

Budapest, Hungary

Istvan Elekes

This inventor holds 18 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Richter Gedeon Vegyeszeti Gyar Rt, Biogal Gyogyszergyar, Egis Gyogyszergyar. Active years: 1976-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Istvan Elekes. Retrieved from https://idiyas.com/inventor/istvan-elekes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 9.5

ph-index = 8

Forward Citations = 194(Granted Patents)


Company Filing History:

goldMedal6 out of 346 
 
Richter Gedeon Vegyeszeti Gyar Rt
 patents
silverMedal3 out of 19 
 
Biogal Gyogyszergyar
 patents
bronzeMedal3 out of 46 
 
Egis Gyogyszergyar
 patents
4. 1 out of 24 
 
Alkaloida Vegyeszeti Gyar
 patents
5. 1 out of 52 
 
Basfaktiengesellschaft
 patents
6. 1 out of 283 
 
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
 patents
7. 1 out of 62 
 
Egyt Gyogyszervegyeszeti Gyar
 patents
8. 1 out of 1 
 
Gyogyszer- Es Vegyeszeti Termekek Gyara Rt.
 patent
9. 1 out of 6 
 
Gyogyszerkutato Intezet
 patents

Years Active: 1976-1991

Loading Chart...
Areas of Expertise:
Pharmaceutical Composition
Alkylene Diamine Derivatives
Benzodiazepine Derivatives
Dihydropyridines
Pyridazinones
Aminoguanidine Compounds
Anorexigenic Compounds
Lysergic Acid Amides
Oxazoline Derivatives
Thiazole Derivatives
Hypotensive Compositions
Morpholino Compounds
18 patents (USPTO):Explore Patents
1. 5047396 - Intravenous pharmaceutical composition and process for preparing the same (1991-09-10),
2. 4922021 - New alkylene diamine derivatives (1990-05-01),
3. 4840948 - 1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical (1989-06-20),
4. 4835152 - 1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-b (1989-05-30),
5. 4829076 - Novel dihydropyridines having calcium antagonistic and antihypertensive (1989-05-09),
6. 4826845 - 3(2H)-pyridazinones and pharmaceutical compositions thereof (1989-05-02),
7. 4785104 - 3-(hydroxymethyl)-isoquinoline derivatives (1988-11-15),
8. 4731383 - Aminoguanidine compounds, their compositions and pharmaceutical uses (1988-03-15),
9. 4614740 - 5H-2,3-benzodiazepine derivatives and pharmaceutical compositions (1986-09-30),
10. 4308386 - Novel pyridazinylhydrazones and method of administering same (1981-12-29),
11. 4308278 - Anorexigenic 4-[(3,4-dialkoxyphenyl)alkyl]-2-imidazolidinone derivatives (1981-12-29),
12. 4259328 - Morpholino pyridazinylhydrazones (1981-03-31),
13. 4251658 - 3-(1-Pyrazolyl)-pyridazine derivatives (1981-02-17),
14. 4224325 - 3-(1-Pyrazolyl)-pyridazine derivatives and hypotensive compositions (1980-09-23),
15. 4119633 - 2-Phenoxy and 2-phenylthio and 2-phenylamino-alkyl-2-oxazolines (1978-10-10),

Title: The Innovative Contributions of Istvan Elekes

Introduction

Istvan Elekes is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, holding a total of 18 patents. His work focuses on developing innovative compositions and processes that enhance medical treatments.

Latest Patents

Among his latest patents is an intravenous pharmaceutical composition that comprises cyclosporin as the active ingredient. This invention aims to improve the delivery and efficacy of this important medication. Additionally, he has developed new alkylene diamine derivatives, specifically 1-(2,6-Dimethyl-Phenyl-amino)-2-Dimethyl-amino-Propane, which is useful for treating cardiac rhythm disorders.

Career Highlights

Throughout his career, Istvan Elekes has worked with notable companies such as Richter Gedeon Vegyeszeti Gyar Rt and Biogal Gyogyszergyar. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Sandor Elek and Istvan Polgari. Their collaborative efforts have further advanced the research and development of pharmaceutical solutions.

Conclusion

Istvan Elekes continues to be a driving force in the pharmaceutical industry, with his innovative patents and collaborations paving the way for future advancements in medical treatments. His contributions are invaluable to the field and demonstrate the impact of dedicated inventors in improving healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…